Sydney Rosen | Profiles RNS

Sydney Rosen, MPA

Research Professor

Boston University School of Public Health

Global Health

MPA, Harvard University
AB, Harvard University

Websites

	School of Public Health Faculty
	Health Economics and Epidemiology Research Office, Johannesburg
	Google Scholar
	LinkedIn
	BUSPH’s Program on the Economics and Epidemiology of HIV in Africa
	The AMBIT project
	ResearchGate
	Tuberculosis Interdisciplinary Approach to Research Alliance (TIARA)

ORCID : 0000-0002-6560-2964

Sydney Rosen, M.P.A., is a Research Professor in the Department of Global Health at the Boston University School of Public Health and a Co-Director of the Health Economics and Epidemiology Research Office (HE2RO) of the University of the Witwatersrand in Johannesburg, South Africa. Her research addresses the economic consequences of the HIV/AIDS epidemic, and in particular the outcomes, costs, cost-effectiveness, and benefits of HIV and TB care and treatment interventions and models of service delivery. She is the principal investigator of multiple USAID-, NIH-, and foundation-supported studies and evaluations in South Africa and has worked extensively in Zambia, Malawi, and Kenya. She is also the author of policy and review papers on the business response to AIDS, the rationing of antiretroviral therapy, and the retention of patients in HIV/AIDS care and treatment programs. Her current projects include AMBIT, EVIDENCE, and EQUIP, all described on the BUSPH website. Professor Rosen’s technical training is in policy analysis and applied economics. She holds a BA magna cum laude from Harvard University and an MPA from the Kennedy School of Government at Harvard.

Co-Division Head
University of the Witwatersrand
Health Economics and Epidemiology Research Office

BU Research

“Evaluating differentiated service delivery for HIV in Africa (AMBIT 2.0)”
12/01/2022 - 12/31/2024 (Subcontract PI)
The Health Economics and Epidemiology Research Office (HE2RO) Bill & Melinda Gates

Retain6: Models of Care for the First 6 months of HIV Treatment
10/12/2021 - 12/31/2024 (PI)
Bill and Melinda Gates Foundation

Simulator-Based simplified Focused Cardiac Ultrasound (sFoCUS) Training in Haiti
06/23/2022 - 03/31/2024 (Subcontract PI)
Boston Medical Center Corporation NIH FIC
5R21TW012165-02

Evaluation of the Central Chronic Medicines Dispensing and Distribution (CCMDD)
06/01/2023 - 12/31/2023 (Subcontract PI)
The Health Economics and Epidemiology Research Office (HE2RO) Bill & Melinda Gates

Evaluation to Inform Decisions using Economics and Epidemiology (The EVIDENCE Project)
01/01/2019 - 11/30/2023 (Subcontract PI)
The Health Economics and Epidemiology Research Office (HE2RO) USAID
72067419CA00004

Alternative Models of ART Delivery: Optimizing the Benefits (AMBIT)
08/08/2018 - 12/31/2022 (PI)
Bill and Melinda Gates Foundation

EQUIP Years 2-5
10/01/2016 - 09/30/2022 (Subcontract PI)
Right to Care (South Africa) USAID

Improving Pre-ART to improve linkage and retention to care in HIV high burden countries
09/22/2015 - 01/31/2021 (PI)
Bill and Melinda Gates Foundation

The Boston University Clinical HIV/AIDS Research Training Program (BU-CHART)
07/01/2018 - 07/31/2020 (Subcontract PI)
Boston Medical Center Corporation NIH NIAID
5T32AI052074-14

INROADS: Innovations Research on HIV/AIDS
01/01/2014 - 12/31/2018 (Subcontract PI)
WITS Health Consortium (PTY) LTD USAID

Showing 10 of 16 results. Show All Results

Title

Yr	Title	Project-Sub Proj	Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Benade M, Mchiza Z, Raquib RV, Prasad SK, Yan LD, Brennan AT, Davies J, Sudharsanan N, Manne-Goehler J, Fox MP, Bor J, Rosen SB, Stokes AC. Health systems performance for hypertension control using a cascade of care approach in South Africa, 2011-2017. PLOS Glob Public Health. 2023; 3(9):e0002055.View Related Profiles.

Brennan, Alana
Stokes, Andrew
Bor, Jacob
Yan, Lily
Fox, Matthew
Rosen, Sydney

PMID: 37676845; PMCID: PMC10484448; DOI: 10.1371/journal.pgph.0002055;

Samet JH, Blokhina E, Cheng DM, Rosen S, Lioznov D, Lunze K, Truong V, Gnatienko N, Quinn E, Bushara N, Raj A, Krupitsky E. Rapid access to antiretroviral therapy, receipt of naltrexone, and strengths-based case management versus standard of care for HIV viral load suppression in people with HIV who inject drugs in Russia (LINC-II): an open-label, randomised controlled trial. Lancet HIV. 2023 Sep; 10(9):e578-e587.View Related Profiles.

Cheng, Debbie
Samet, Jeffrey
Lunze, Karsten
Rosen, Sydney

PMID: 37659841

Jo Y, Jamieson L, Phiri B, Grimsrud A, Mwansa M, Shakwelele H, Haimbe P, Mukumbwa-Mwenechanya M, Mulenga PL, Nichols BE, Rosen S. Attrition from HIV treatment after enrollment in a differentiated service delivery model: A cohort analysis of routine care in Zambia. PLoS One. 2023; 18(3):e0280748.View Related Profiles.

Nichols, Brooke
Rosen, Sydney

PMID: 36917568; PMCID: PMC10013882; DOI: 10.1371/journal.pone.0280748;

Kileel EM, Zheng A, Bor J, Fox MP, Crowther NJ, George JA, Khoza S, Rosen S, Venter WD, Raal F, Hibberd P, Brennan AT. Does engagement in HIV care affect screening, diagnosis, and control of noncommunicable diseases in sub-Saharan Africa? A systematic review and meta-analysis. medRxiv. 2023 Feb 01.View Related Profiles.

Brennan, Alana
Bor, Jacob
Fox, Matthew
Hibberd, Patricia
Rosen, Sydney

PMID: 36778439; PMCID: PMC9915817; DOI: 10.1101/2023.01.30.23285196;

Jamieson L, Rosen S, Phiri B, Grimsrud A, Mwansa M, Shakwelele H, Haimbe P, Mukumbwa-Mwenechanya M, Lumano-Mulenga P, Chiboma I, Nichols BE. How soon should patients be eligible for differentiated service delivery models for antiretroviral treatment? Evidence from a retrospective cohort study in Zambia. BMJ Open. 2022 Dec 22; 12(12):e064070.View Related Profiles.

Nichols, Brooke
Rosen, Sydney

PMID: 36549722; PMCID: PMC9772670; DOI: 10.1136/bmjopen-2022-064070;

Antoniak S, Chasela CS, Freiman MJ, Stopolianska Y, Barnard T, Gandhi MM, Liulchuk M, Tsenilova Z, Viktor T, Dible J, Wose Kinge C, Akpan F, Minior T, Sigwebela N, Mohamed S, Barralon M, Marange F, Cavenaugh C, Horst CV, Antonyak S, Xulu T, Chew KW, Sanne I, Rosen S. Treatment outcomes and costs of a simplified antiretroviral treatment strategy for hepatitis C among Hepatitis C Virus and Human Immuno deficiency Virus co-infected patients in Ukraine. JGH Open. 2022 Dec; 6(12):894-903.View Related Profiles.

Sanne, Ian
Rosen, Sydney

PMID: 36514496; PMCID: PMC9730727; DOI: 10.1002/jgh3.12839;

Guthrie T, Muheki C, Rosen S, Kanoowe S, Lagony S, Greener R, Miot J, Balidawa H, Kiggundu J, Calnan J, Dejene S, Xulu T, Sigwebela N, Long LC. Similar costs and outcomes for differentiated service delivery models for HIV treatment in Uganda. BMC Health Serv Res. 2022 Nov 03; 22(1):1315.View Related Profiles.

Long, Lawrence
Rosen, Sydney

PMID: 36329450; PMCID: PMC9635081; DOI: 10.1186/s12913-022-08629-4;

Benade M, Long L, Meyer-Rath G, Miot J, Evans D, Tucker JM, Moultrie H, Rosen S. Reduction in initiations of drug-sensitive tuberculosis treatment in South Africa during the COVID-19 pandemic: Analysis of retrospective, facility-level data. PLOS Glob Public Health. 2022; 2(10):e0000559.View Related Profiles.

Meyer-Rath, Gesine
Long, Lawrence
Rosen, Sydney

PMID: 36962535; PMCID: PMC10021649; DOI: 10.1371/journal.pgph.0000559;

Meyer-Rath, Gesine
Long, Lawrence
Rosen, Sydney

PMID: 36962535; PMCID: PMC10021649; DOI: 10.1371/journal.pgph.0000559;

Benade M, Long LC, Meyer-Rath G, Miot J, Evans D, Tucker JM, Moultrie H, Rosen S. Reduction in initiations of tuberculosis treatment in South Africa during the COVID pandemic. PLOS Global Public Health. 2022; 2(10):e0000559. View Publication

Showing 10 of 150 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 149 publications over 23 distinct years, with a maximum of 15 publications in 2021